(Q43967448)

28 November 2017

title

Tumor necrosis factor-alpha and transforming growth factor-beta reflect severity of liver damage in primary biliary cirrhosis (English)

1 reference

primary biliary cholangitis

28 November 2017

0 references

0 references

author name string

Manuela Neuman

1

1 reference

28 November 2017

Paul Angulo

2

1 reference

28 November 2017

Izabella Malkiewicz

3

1 reference

28 November 2017

Roberta Jorgensen

4

1 reference

28 November 2017

Neil Shear

5

1 reference

28 November 2017

E Rolland Dickson

6

1 reference

28 November 2017

Julia Haber

7

1 reference

28 November 2017

Gady Katz

8

1 reference

28 November 2017

Keith Lindor

9

1 reference

28 November 2017

language of work or name

1 reference

1 February 2002

1 reference

Journal of Gastroenterology and Hepatology

28 November 2017

published in

1 reference

28 November 2017

volume

17

1 reference

28 November 2017

issue

2

1 reference

28 November 2017

page(s)

196-202

1 reference

A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02672.X

Ursodeoxycholic acid treatment in patients with primary biliary cirrhosis. A Swedish multicentre, double-blind, randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02672.X

Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02672.X

Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02672.X

Ursodeoxycholic acid for primary biliary cirrhosis: lessons from the past--issues for the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02672.X

Hepatocyte and immune system: acute phase reaction as a contribution to early defence mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02672.X

21 January 2018

Cytokines and the liver

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02672.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02672.X

Tumour necrosis factor, cholestatic jaundice, and chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02672.X

Cytokines as predictors for sustained response and as markers for immunomodulation in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02672.X

Prognosis in primary biliary cirrhosis: model for decision making

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02672.X

Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02672.X

Role of cytokines in ethanol-induced cytotoxicity in vitro in Hep G2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02672.X

Ductular expression of autoantigens in primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02672.X

Lymphocyte responses and cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02672.X

Bile duct epithelia as target cells in primary biliary cirrhosis and primary sclerosing cholangitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02672.X

Predictive factors in ursodeoxycholic acid-treated patients with primary biliary cirrhosis: role of serum markers of connective tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02672.X

10.1046/J.1440-1746.2002.02672.X

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference